6th Nov 2009 11:52
| 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES  | 
| 
 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:  | 
 
 Deltex Medical Group plc  | 
| 
 2 Reason for the notification (please tick the appropriate box or boxes):  | 
||
| 
 An acquisition or disposal of voting rights  | 
 No  | 
|
| 
 An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  | 
 No  | 
|
| 
 An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  | 
 No  | 
|
| 
 An event changing the breakdown of voting rights  | 
 No  | 
|
| 
 Other (please specify):  | 
 Placing  | 
 Yes  | 
| 
 3. Full name of person(s) subject to the notification obligation:  | 
 Gartmore Investment Limited  | 
| 
 4. Full name of shareholder(s) (if different from 3.):  | 
 See attached schedule  | 
| 
 5. Date of the transaction and date on which the threshold is crossed or reached:  | 
 3rd November 2009  | 
| 
 6. Date on which issuer notified:  | 
 4th November 2009  | 
| 
 7. Threshold(s) that is/are crossed or reached:  | 
 5%  | 
| 
 8. Notified details:  | 
|||||||
| 
 A: Voting rights attached to shares  | 
|||||||
| 
 Class/type of shares if possible using the ISIN CODE  | 
 Situation previous to the triggering transaction  | 
 Resulting situation after the triggering transaction  | 
|||||
| 
 Number of Shares  | 
 Number of Voting Rights  | 
 Number of shares  | 
 Number of voting rights  | 
 % of voting rights  | 
|||
| 
 Direct  | 
 Direct  | 
 Indirect  | 
 Direct  | 
 Indirect  | 
|||
| 
 GB0059337583  | 
 n/a  | 
 n/a  | 
 12,401,111  | 
 
  | 
 12,401,111  | 
 
  | 
 9.953%  | 
| 
 
  | 
|||||||
| 
 B: Qualifying Financial Instruments  | 
||||
| 
 Resulting situation after the triggering transaction  | 
||||
| 
 Type of financial instrument  | 
 Expiration date  | 
 Exercise/ Conversion Period  | 
 Number of voting rights that may be acquired if the instrument is exercised/ converted.  | 
 % of voting rights  | 
| 
 
  | 
 
  | 
 
  | 
 
  | 
 
  | 
| 
 C: Financial Instruments with similar economic effect to Qualifying Financial Instruments  | 
||||||
| 
 Resulting situation after the triggering transaction  | 
||||||
| 
 Type of financial instrument  | 
 Exercise price  | 
 Expiration date  | 
 Exercise/ Conversion period  | 
 Number of voting rights instrument refers to  | 
 % of voting rights  | 
|
| 
 
  | 
 
  | 
 
  | 
 
  | 
 
  | 
 Nominal  | 
 Delta  | 
| 
 
  | 
 
  | 
|||||
| 
 Total (A+B+C)  | 
|
| 
 Number of voting rights  | 
 Percentage of voting rights  | 
| 
 12,401,111  | 
 9.953%  | 
| 
 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:  | 
| 
 
  | 
| 
 Proxy Voting:  | 
|
| 
 10. Name of the proxy holder:  | 
 
  | 
| 
 11. Number of voting rights proxy holder will cease to hold:  | 
 
  | 
| 
 12. Date on which proxy holder will cease to hold voting rights:  | 
 
  | 
| 
 13. Additional information:  | 
 All figures are based on the Company's issued share capital of 124,598,597 as provided by Exshare E mail contact [email protected]  | 
| 
 14. Contact name:  | 
 RDU  | 
| 
 15. Contact telephone number:  | 
 0207 782 2324  | 
Report S793 Current Holdings By Instrument Type 04 NOV 2009 11:43
Page 1 of 1
Stock Line: 3103865 DELTEX MEDICAL GRP ORD GBP0.01 Issued Share Capital: 124,598,597
| 
 Share Description Fund Managing Co.  | 
 Shares Held  | 
 % of Issues Share Capital  | 
 UK Registered Owner  | 
 Beneficial Owner  | 
| 
 Equities DELTEX MEDICAL GRP ORD GBP0.01 Gartmore Fund Managers Limited 
 Gartmore Investment Limited  | 
 6,172,831 6,228,280  | 
 4.954% 4.999%  | 
 HSBC GLOBAL CUSTODY NOMINEE UK LIMITED VIDACOS NOMINEES LTD A/C 2303  | 
 GARTMORE FUND MANAGERS LTD A/C GARTMORE UK & IRISH SMALLER COMPANIES THE ALPHAGEN VOLANTIS FUND LIMITED  | 
| 
 12,401,111  | 
 9.953%  | 
|||
| 
 12,401,111  | 
 9.953%  | 
End of Report
Related Shares:
Deltex Medical